Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Jul 30, 2026 | −$0.90 | — | $334.98M | +44.3% | −$0.41 |
| Q1 FY26ended Mar 31, 2026 | May 7, 2026 | −$0.85 | — | $301.67M | +48.3% | −$0.47 |
| Q4 FY25ended Dec 31, 2025 | — | −$1.00 | — | $281.27M | +39.4% | — |
| Q3 FY25ended Sep 30, 2025 | — | −$0.74 | — | $265.20M | +38.5% | — |
| Q2 FY25ended Jun 30, 2025 | — | −$0.80 | — | $232.09M | +30.9% | — |
| Q1 FY25ended Mar 31, 2025 | — | −$0.77 | — | $203.47M | +20.8% | — |
| Q4 FY24ended Dec 31, 2024 | — | −$0.90 | — | $201.81M | +30.2% | — |
| Q3 FY24ended Sep 30, 2024 | — | −$0.88 | — | $191.48M | +33.9% | — |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Guardant Health shares, not any token. As of Jul 30, 2026, from Massive's standardised financials and the earnings calendar.
| Q2 FY24ended Jun 30, 2024 |
| — |
| −$0.84 |
| — |
| $177.24M |
| — |
| — |
| Q1 FY24ended Mar 31, 2024 | — | −$0.94 | — | $168.49M | — | — |
| Q4 FY23ended Dec 31, 2023 | — | −$1.58 | — | $155.05M | — | — |
| Q3 FY23ended Sep 30, 2023 | — | −$0.73 | — | $143.03M | — | — |